We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

ReShape Lifesciences Inc (RSLS) USD0.001

Sell:$0.56 Buy:$0.58 Change: $0.0165 (2.86%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.0165 (2.86%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
Change: $0.0165 (2.86%)
Market closed |  Prices as at close on 1 July 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ReShape Lifesciences Inc. is a weight-loss solutions company. The Company is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its portfolio includes Lap-Band system, which provides minimally invasive, long-term treatment of obesity and is a safer surgical alternative to more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy. Its reshapecare virtual health coaching program is a reimbursed telehealth weight-management program that supports healthy lifestyle changes for all medically managed weight-loss patients. Its ReShape Marketplace is an online store, that provides a line of products for bariatric patients. Its ReShape Optimize supplement options include multivitamins, probiotics, calcium, vitamin D, protein and other therapeutic offerings to optimize health. Its ReShape Vest is an investigational, minimally invasive, laparoscopically implanted medical device.

Contact details

United States
+1 (949) 4296680

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$10.54 million
Shares in issue:
18.69 million
Health Care Equipment
United States
US dollar

Key personnel

  • Dan Gladney
    Chairman of the Board
  • Andrew Rasdal
    President, Chief Executive Officer
  • Thomas Stankovich
    Chief Financial Officer
  • Michael Bordainick
    Senior Vice President - Commercial Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.